RARE DISEASERESEARCH ATLAS
Open navigation menu

ORPHA:464306

DYRK1A-related intellectual disability syndrome

low confidenceDisorder

Also known as: DYRK1A syndrome

Publications

5,204

Trials

0

Interventional, condition-specific

Researchers

498

Distinct authors in sample

Gene link

DYRK1A

Definitive

Readiness

4/6

Stages with a signal

Clinical definition (Orphanet)

A rare genetic syndromic characterized by microcephaly, global , mild to severe , impairment of speech, feeding problems, behavior problems (often autism spectrum disorder) and facial features (such as prominent ears, deep-set eyes, a short nose with a broad nasal tip, and retrognathia with a broad chin). Other, more variable manifestations include , short stature, ocular anomalies, cardiac anomalies, urogenital anomalies and musculoskeletal defects.

How rare: <1 / 1 000 000 — fewer than one in a million. In a city the size of Kolkata, that might mean on the order of fifteen people.

Orphanet entry

Cross-references

Joined from Mondo / Orphanet. MeSH labels may enter searches; UMLS / OMIM / NCIT are stored for reference.

Additional Mondo synonyms (4)

MRD7 · autosomal dominant intellectual disability 7 · intellectual disability, autosomal dominant type 7 · mental retardation, autosomal dominant type 7

Research stages

Trial readiness signals

Where this condition sits on an open-data research pipeline — not how close a treatment is, and not medical advice. Empty stages often mean “not in these databases under this Mondo ID,” not “impossible.”

4/6 stages with a signal

No matched interventional trial, but a gene association and an animal model are on record — often described as translation-ready / stalled at the clinical step.

  1. Gene identifiedPresent

    Definitive — DYRK1A

  2. LiteraturePresent

    5,204 matched papers (3,736 in last 10 years) Source

  3. Phenotype characterisedPresent

    297 HPO annotations (e.g. Downslanted palpebral fissures; Macrotia; Sacral dimple) Source

  4. Animal modelPresent

    1 genotype model (Mus musculus) Source

  5. Orphan designationNot found

    No FDA or EMA orphan-drug designation matched this disease via UMLS or preferred name Source

  6. Interventional trialNot found

    No matched interventional trial under our ClinicalTrials.gov rules

Biology

Genes and phenotypes

Gene–disease validity from GenCC, plus phenotypes and animal models joined from Monarch Initiative via Mondo ID — not a clinical diagnosis aid.

Do we know what causes it?

Yes — we know a specific gene responsible (DYRK1A).

GenCC classification: Definitive.

Phenotypes (Monarch / HPO)

297

Associated phenotypes · MONDO:0013578

  • Downslanted palpebral fissures
  • Macrotia
  • Sacral dimple
  • Low-set ears
  • Hydronephrosis

Showing 5 of 297 — open Monarch for the full list.

Animal models (Monarch / Alliance)

1

Model associations linked to this Mondo ID

Monarch fetch 2026-07-29

Therapies

Designations, candidates, and chemicals

FDA OOPD and EMA orphan designations, Open Targets clinical candidates, and CTD chemical associations via MyDisease.info. These never change the interventional-trial headline.

Orphan designation (FDA · EMA)

No designation matched this disease via UMLS or preferred name on the FDA OOPD mirror or EMA orphan register. Absence here is not proof that none exists under another wording.

Open Targets candidates

No drugs or clinical candidates returned for this Mondo ID on Open Targets.

CTD chemicals (MyDisease.info)

No CTD chemical associations returned for this Mondo ID.

Literature

Is anyone studying this?

5,204

5,204 papers — among the better-studied rare conditions, though still a fraction of common-disease literature (breast cancer: over 700,000). Median papers in the last 10 years for a rare disease in this dataset (publications denominator n=3967) is 59.

5,204 papers since the earliest indexed year in this search — median last-10-year count for a rare disease in this dataset is 59 (publications denominator n=3967).

3,736 in the last 10 years · low confidence

Phrase hits: 73 · MeSH hits: 0

Open Europe PMC search

Who's working on it?

498

Distinct author names in 73 sampled papers — named people below.

Who's working on it?

No interventional trial matched this name; these authors publish on it in the sampled literature — a practical starting point for contact.

  1. 01
    Piton A8 papers · 2026

    Department of Translational Medicine and Neurogenetics, IGBMC, CNRS UMR 7104, INSERM U964, Strasbourg University, Strasbourg, France.

    Papers in Europe PMC
  2. 02
    Mandel JL6 papers · 2026

    Department of Translational Medicine and Neurogenetics, IGBMC, CNRS UMR 7104, INSERM U964, Strasbourg University, Strasbourg, France.

    Papers in Europe PMC
  3. 03
    Courraud J5 papers · 2026

    Institut de Génétique et de Biologie Moléculaire et Cellulaire, Illkirch, France.

    Papers in Europe PMC
  4. 04
    Eichler EE5 papers · 2025

    Department of Genome Sciences, University of Washington School of Medicine, Seattle, WA, USA.

    Papers in Europe PMC
  5. 05
    Arbonés ML4 papers · 2022

    Instituto de Biología Molecular de Barcelona (IBMB), CSIC, 08028 Barcelona, Spain; Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Barcelona, Spain. Electronic address: marbmc@ibmb.csic.es.

    Papers in Europe PMC
  6. 06
    Balducci E4 papers · 2022

    Instituto de Biología Molecular de Barcelona (IBMB), CSIC, 08028 Barcelona, Spain; Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Barcelona, Spain.

    Papers in Europe PMC
  7. 07
    Barallobre MJ4 papers · 2022

    Instituto de Biología Molecular de Barcelona (IBMB), CSIC, 08028 Barcelona, Spain; Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Barcelona, Spain.

    Papers in Europe PMC
  8. 08
    Bernier RA4 papers · 2025

    Department of Psychiatry and Behavioral Sciences, University of Washington School of Medicine, Seattle, WA, USA.

    Papers in Europe PMC
  9. 09
    Durand B4 papers · 2024

    Institut de Génétique et de Biologie Moléculaire et Cellulaire, Illkirch, France.

    Papers in Europe PMC
  10. 10
    Isidor B4 papers · 2024

    Medical Genetics- Clinical Genetics Unit, CHU de Nantes, Nantes-Cedex, France.

    Papers in Europe PMC

Clinical research

Is a treatment being tested?

0

interventional trials for this specific condition

No interventional trial testing a treatment matched this specific condition name on ClinicalTrials.gov (observational studies and pan-disease registries are listed separately when present).

Data as of 11 September 2026 · last trial check 11 September 2026

No matched interventional trials. This is true for 77.2% of diseases in the trials denominator (5501 of 7126). Here are the researchers publishing on it.

low confidence · 38.6th percentile (trials denominator)

Recruiting interventional trials

From the matched ClinicalTrials.gov set

No interventional trial testing a treatment was found for this specific condition name on ClinicalTrials.gov.

See who's working on it — people publishing on this disease are often the practical next contact when no trial is listed.

Other registries (secondary)

Broader net from EU CTIS, ISRCTN, and ICTRP when available — deduped against ClinicalTrials.gov IDs already counted above. Dual-model LLM relevance gates what we keep. These rows are not added to the interventional headline.

raw 0 · after dedupe 0 · already on CT.gov 0 · kept 0 · parent 0 · uncertain 0 · dropped 0 · fetched 2026-07-30

Source notes: ictrp: Error: ICTRP public search unavailable (WHO portal is SPA-only; SOAP needs partnership). Tried: https://apps.who.int/tri

No secondary-registry studies passed dual-model relevance for this condition name (after dedupe).

Where to find support

Condition-specific patient organisations, when Orphanet lists them, are on the disease’s Orphanet page. We also link umbrella groups that support undiagnosed and ultra-rare families.

Orphanet entry for DYRK1A-related intellectual disability syndrome — check Associations / patient organisations on that page.

India — NPRD

Last verified 2026-07-26

This ORPHAcode is not on our curated NPRD list (direct or Mondo-parent match). That does not decide clinical eligibility; families in India should ask a notified Centre of Excellence about current coverage.

Hand-curated for this project. ORPHAcode mappings are best-effort and may be incomplete or imprecise for umbrella categories. Parent (Mondo) matches mean the policy lists a broader category — confirm eligibility with a Centre of Excellence. Financial entitlements summarised from public policy statements and may change. This is not official government guidance.

How we counted this

Europe PMC query (preferred label + any corrected label + Orphanet and Mondo exact synonyms, stoplisted; unioned with resolved MeSH labels when available). UMLS / OMIM / NCIT cross-references are stored on the overview but are not added to the query string.

("DYRK1A-related intellectual disability syndrome" OR "DYRK1A syndrome" OR "autosomal dominant intellectual disability 7" OR "intellectual disability, autosomal dominant type 7" OR "mental retardation, autosomal dominant type 7") OR ("DYRK1A" OR "DYRK1A-related")

Run this search on Europe PMC

ClinicalTrials.gov query (quoted phrases + MeSH via query.cond, plus recall-expansion terms when used):

"DYRK1A-related intellectual disability syndrome" OR "DYRK1A syndrome" OR "autosomal dominant intellectual disability 7" OR "intellectual disability, autosomal dominant type 7" OR "mental retardation, autosomal dominant type 7"

Study-type breakdown: 0 interventional · 0 observational · 0 expanded access. Only interventional studies enter the trial headline.

Query health: ok — strategies attempted: phrase; with hits: phrase

Run this search on ClinicalTrials.gov

Synonyms dropped by stoplist: MRD7

Confidence reasoning

  • Preferred label is multi-word and distinctive
  • 1 synonym(s) dropped by stoplist (may under-count)
  • No label/synonym collisions with other diseases in this corpus
  • Publication count (5204) is implausibly high for prevalence class "<1 / 1 000 000" — treat as possible over-matching, not a measure of research intensity

Ingested 2026-07-27T16:54:22.724Z